Simplify and standardize breast density reporting and stratification with PowerLook® Density Assessment. The latest generation of our advanced software offers improved accuracy, providing clinicians with reliable and replicable results.2
Using mammographic images, PowerLook Density Assessment analyzes the woman’s breast anatomy and categorizes her breast density within the appropriate BI-RADS® 5th edition density category.
This innovative solution automates the process of breast density reporting and empowers clinicians to further personalize breast cancer screening recommendations for patients.
We applaud the FDA’s recent announcement of a national dense breast reporting standard.
Ready to standardize your read?
PowerLook Density Assessment software is the ideal choice for those seeking to accurately automate density assessment and harmonize the patient experience.
The algorithm analyzes synthetic images generated from 3D mammography for dispersion and texture of breast tissue, delivering clinicians unique and patient-specific breast density assessments.
It identifies the patient’s anatomy, segments the breast, then measures adipose and fibroglandular tissue and its dispersion to determine the density category in alignment with BI-RADS® 5th Edition lexicon.
Objective, reliable
and consistent breast
density assessmentsHighest matching accuracy for dense and non-dense assessment on the market1,2
Seamless integration within multiple PACS, reading workstations and RIS/MIS
Breast 1 may have a higher percentage of densebreast tissue by volume, but Breast 2 has the greaterchance of obscuring a cancerous lesion.
Breast density assessment has traditionally been determined by the radiologist’s visual assessment, but studies show that these can vary, and clinicians may even disagree with their own assessment year to year.3 This can be confusing for patients, lead to unnecessary additional imaging, and increase patient and facility costs.
PowerLook Density Assessment software removes the challenges of subjectivity in breast density reporting. Using full field digital mammography (FFDM) or synthetic 2D images, it analyzes the dispersion and texture of breast tissue, delivering clinicians a consistent, accurate, and reliable patient-specific breast density assessment.
iCAD’s product portfolio offers innovative solutions to support breast cancer detection, measure breast density, assess personalized risk, and provide targeted radiation therapy. Our technologies offer clinically proven benefits to clinicians and patients, and are designed to optimize efficiency, enhance the patient experience, and improve outcomes.
Thank you. An iCAD representative will contact you shortly.
References:
© iCAD Inc. All rights reserved. iCAD, the iCAD logo, PowerLook, ProFound AI, ProFound, Xoft, the Xoft logo, Axxent, Electronic Brachytherapy System and eBx are registered trademarks of iCAD, Inc. Reproduction of any of the material contained herein in any format or media without the express written permission of iCAD, Inc. is prohibited.
Breast 1 may have a higher percentage of densebreast tissue by volume, but Breast 2 has the greaterchance of obscuring a cancerous lesion.Dense breasts can make it challenging to detect breast cancer during annual screenings as overlapping tissue can hide or mimic breast cancer, even with digital breast tomosynthesis (DBT) exams.